Welcome to LookChem.com Sign In|Join Free

CAS

  • or
(1R,2R)-Ethyl2-(3,4-difluorophenyl)cyclopropane carboxylate is a chiral cyclopropane derivative featuring a carboxylate group and a difluorophenyl moiety. It is characterized by its unique stereochemistry and structural properties, which make it a valuable compound for various applications in the pharmaceutical and chemical industries.

1006376-61-9 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1006376-61-9 Structure
  • Basic information

    1. Product Name: (1R,2R)-ethyl2-(3,4-difluorophenyl)cyclopropane carboxylate
    2. Synonyms: (1R,2R)-ethyl2-(3,4-difluorophenyl)cyclopropane carboxylate;Cyclopropanecarboxylic acid, 2-(3,4-difluorophenyl)-, ethyl ester,(1R,2R)-;(1R,2R)-2-(3,4-Difluorophenyl)cyclopropanecarboxylic acid ethyl ester;ethyl(1R,2R)-2-(3,4-difluorophenyl)cyclopropane-1-carboxylate
    3. CAS NO:1006376-61-9
    4. Molecular Formula: C12H12F2O2
    5. Molecular Weight: 226.2192864
    6. EINECS: 919-127-6
    7. Product Categories: N/A
    8. Mol File: 1006376-61-9.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 262.7±40.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.257±0.06 g/cm3(Predicted)
    6. Refractive Index: N/A
    7. Storage Temp.: Sealed in dry,Room Temperature
    8. Solubility: N/A
    9. CAS DataBase Reference: (1R,2R)-ethyl2-(3,4-difluorophenyl)cyclopropane carboxylate(CAS DataBase Reference)
    10. NIST Chemistry Reference: (1R,2R)-ethyl2-(3,4-difluorophenyl)cyclopropane carboxylate(1006376-61-9)
    11. EPA Substance Registry System: (1R,2R)-ethyl2-(3,4-difluorophenyl)cyclopropane carboxylate(1006376-61-9)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1006376-61-9(Hazardous Substances Data)

1006376-61-9 Usage

Uses

Used in Pharmaceutical Research:
(1R,2R)-Ethyl2-(3,4-difluorophenyl)cyclopropane carboxylate is used as a key intermediate in the synthesis of ticagrelor derivatives, which are antiplatelet agents. Its application is crucial for studying the inhibitory effects of these derivatives on ADP-induced platelet aggregation, a significant factor in the development of cardiovascular diseases.
Used in Chemical Synthesis:
In the chemical industry, (1R,2R)-ethyl2-(3,4-difluorophenyl)cyclopropane carboxylate serves as a versatile building block for the development of novel compounds with potential applications in various fields, such as materials science, agrochemistry, and pharmaceuticals. Its unique structural features allow for further functionalization and modification to create new molecules with desired properties.

Check Digit Verification of cas no

The CAS Registry Mumber 1006376-61-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,6,3,7 and 6 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1006376-61:
(9*1)+(8*0)+(7*0)+(6*6)+(5*3)+(4*7)+(3*6)+(2*6)+(1*1)=119
119 % 10 = 9
So 1006376-61-9 is a valid CAS Registry Number.

1006376-61-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl (1R,2R)-2-(3,4-difluorophenyl)cyclopropane-1-carboxylate

1.2 Other means of identification

Product number -
Other names ethyl (1R,2R)-trans-2-(3,4-difluorophenyl)-1-cyclopropanecarboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1006376-61-9 SDS

1006376-61-9Relevant articles and documents

Comparison of a Batch and Flow Approach for the Lipase-Catalyzed Resolution of a Cyclopropanecarboxylate Ester, A Key Building Block for the Synthesis of Ticagrelor

Hugentobler, Katharina G.,Rasparini, Marcello,Thompson, Lisa A.,Jolley, Katherine E.,Blacker, A. John,Turner, Nicholas J.

, p. 195 - 199 (2017)

In this study a batch reactor process is compared to a flow chemistry approach for lipase-catalyzed resolution of the cyclopropanecarboxylate ester (±)-3. (1R,2R)-3 is a precursor of the amine (1R,2S)-2 which is a key building block of the API ticagrelor. For both flow and batch operation, the biocatalyst could be recycled several times, whereas in the case of the flow process the reaction time was significantly reduced.

Controllable stereoinversion in DNA-catalyzed olefin cyclopropanationviacofactor modification

Cheng, Yu,Hao, Jingya,Jia, Guoqing,Li, Can,Lu, Shengmei,Miao, Wenhui

, p. 7918 - 7923 (2021/06/16)

The assembly of DNA with metal-complex cofactors can form promising biocatalysts for asymmetric reactions, although catalytic performance is typically limited by low enantioselectivities and stereo-control remains a challenge. Here, we engineer G-quadruplex-based DNA biocatalysts for an asymmetric cyclopropanation reaction, achieving enantiomeric excess (eetrans) values of up to +91% with controllable stereoinversion, where the enantioselectivity switches to ?72% eetransthrough modification of the Fe-porphyrin cofactor. Complementary circular dichroism, nuclear magnetic resonance, and fluorescence titration experiments show that the porphyrin ligand of the cofactor participates in the regulation of the catalytic enantioselectivityviaa synergetic effect with DNA residues at the active site. These findings underline the important role of cofactor modification in DNA catalysis and thus pave the way for the rational engineering of DNA-based biocatalysts.

Preparation method of phenyl-containing compound

-

, (2022/01/04)

The present invention discloses a method for preparing an phenyl-containing compound. The present invention provides a method for preparing a compound shown in formula I, comprising the following steps: in the presence of formamide or acetamide, in the pr

Preparation method of chiral aromatic cyclopropylamine and salt thereof and intermediate used in preparation method

-

Paragraph 0076-0078, (2020/06/20)

The embodiment of the invention provides a preparation method of a compound as shown in a formula I or salt thereof, which comprises the following steps: (1) reacting a compound as shown in a formulaVI with a compound as shown in a formula VII in a first

Preparation method of ticagrelor

-

Paragraph 0035; 0040; 0044; 0084; 0125, (2018/04/21)

The invention discloses a preparation method of ticagrelor. The preparation method comprises the following steps: (1) preparation of ticagrelor intermediate product 1-TK acid; (2) preparation of ticagrelor intermediate product 2-TK-amide; (3) preparation of ticagrelor intermediate product 3-TK-amino compound hydrochloride; (4) preparation of ticagrelor intermediate product 4-TK-amino compound R-tartrate; ( 5) preparation of ticagrelor intermediate product 5-TK-amino compound L-mandelate; and (6) preparation of ticagrelor-TK. The preparation method has the advantages of cost advantage, mature and stable process, stable product quality, and safe and reliable production process.

Method for preparing ticagrelor intermediate

-

, (2018/03/06)

The invention discloses a method for preparing a ticagrelor intermediate. The method comprises the following steps: taking o-difluorobenzene and chloroacetyl chloride as initial raw materials, carrying out an F-K reaction, a bio-enzyme fermentation technology asymmetric reduction reaction, a ring-closure reaction and a cyclopropanation reaction, so as to obtain the key intermediate (1R, 2R)-2-(3,4-difluorophenyl) cyanocyclopropane carboxylate of the ticagrelor at high yield, high enantioselectivity and high purity. The method can realize industrialized production. The method is low in energy consumption, less in pollution, green, clean, high in yield and high in purity, the cost is reduced, the product quality is stable, and the method is suitable for large-scale stable industrial production.

Development of a Practical Enzymatic Process for Preparation of (S)-2-Chloro-1-(3,4-difluorophenyl)ethanol

Guo, Xiang,Tang, Jia-Wei,Yang, Jiang-Tao,Ni, Guo-Wei,Zhang, Fu-Li,Chen, Shao-Xin

, p. 1595 - 1601 (2017/10/25)

(S)-2-Chloro-1-(3,4-difluorophenyl)ethanol (1) is a vital chiral intermediate for the synthesis of Ticagrelor - an effective treatment for acute coronary syndromes. A ketoreductase (KRED) KR-01 in our KRED library was screened to transform 2-chloro-1-(3,4

(1 R, 2 S) - 2 - (3, 4 - difluorophenyl) amine ·D - mandelic acid salt preparation method

-

Paragraph 0115-0118, (2018/02/04)

The invention discloses a preparation method of (1R,2S)-2-(3,4-difluorophenyl) rolicyprine.D-mandelate. The preparation method comprises the following steps: carrying out cyclopropanation on a compound shown in a formula V to obtain a compound shown in a formula IV; carrying out amide generation and Hofmann degradation to obtain a compound shown in a formula II; and performing salification with D-mandelic acid to obtain a compound shown in a formula I. The compound shown in the formula V is prepared in a way that a compound shown in a structure formula VI is subjected to CBS asymmetric reduction reaction, wherein a catalyst for the CBS asymmetric reduction reaction is a compound shown in a structural formula VII, and a reduction agent for the CBS asymmetric reduction reaction can be borane-tetrahydrofuran or borane-N,N-diethyl phenylamine.

HEMOPROTEIN CATALYSTS FOR IMPROVED ENANTIOSELECTIVE ENZYMATIC SYNTHESIS OF TICAGRELOR

-

Paragraph 0211; 0212; 0221; 0222, (2016/12/22)

The present invention provides methods by which trans-(1R,2S)-2-(3,4-difluorophenyl)-cyclopropylamine and related cyclopropane compounds are prepared using synthetic strategies that include a biocatalytic cyclopropanation step.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1006376-61-9